e-learning
resources
Stockholm 2007
Tuesday 18.09.2007
Longitudinal and cross sectional risk factors for COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Relationship between lung function impairment and incidence or recurrence of cardiovascular disease in a middle-aged cohort
A. Johnston, D. Mannino, V. Kiri, K. Davis, G. Hagan (Lexington, KY, Research Triangle Park, NC, United States Of America; Greenford, Middlesex, United Kingdom)
Source:
Annual Congress 2007 - Longitudinal and cross sectional risk factors for COPD
Session:
Longitudinal and cross sectional risk factors for COPD
Session type:
Oral Presentation
Number:
4020
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Johnston, D. Mannino, V. Kiri, K. Davis, G. Hagan (Lexington, KY, Research Triangle Park, NC, United States Of America; Greenford, Middlesex, United Kingdom). Relationship between lung function impairment and incidence or recurrence of cardiovascular disease in a middle-aged cohort. Eur Respir J 2007; 30: Suppl. 51, 4020
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on acute decompensated pulmonary hypertension
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Prognosis: what is the contribution of inflammation to the decline in lung function in airway disease?
Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease
Year: 2007
Mortality in COPD: role of comorbidities
Source: Eur Respir J 2006; 28: 1245-1257
Year: 2006
Frequency of occurrence of risk factors of cardiovascular diseases and assessment of the total cardiovascular risk in patients with chronic obstructive pulmonary disease (COPD).
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019
COPD coronary/peripheral vascular disease
Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases
Year: 2006
Systemic inflammation and cardiovascular disease in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Year: 2013
Predictive factors for the incidence of lung cancer (LC) complicated in patients with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2019 – Advances in clinical management of COPD
Year: 2019
Prevalence of comorbidities in patients with chronic obstructive pulmonary disease in presence of heart failure
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016
Prevalence, correlates and mortality impact of chronic obstructive pulmonary disease in end stage kidney disease
Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects
Year: 2008
Frequency of adverse consequences after spirography in patients with chronic obstructive pulmonary disease and concomitant ischemic heart disease
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016
Clinical characteristics of postoperative pulmonary infection in lung cancer patients with obstructive pulmonary disease: the trend of microorganisms in bronchial colonization
Source: Annual Congress 2006 - Contemporary issues in thoracic surgical oncology
Year: 2006
COPD prevalence is increased in lung cancer, independent of age, sex and smoking history
Source: Eur Respir J 2009; 33: 380-386
Year: 2009
Inflammation in COPD: a link to systemic comorbidities
Source: Eur Respir Rev 2007; 16: 91-97
Year: 2007
A clinical scoring algorithm to predict all cause mortality in COPD
Source: Annual Congress 2007 - Clinical aspects in COPD
Year: 2007
Relationships between C-reactive protein and disability in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2005 - Systemic effects of COPD
Year: 2005
Socioeconomic risk factors for COPD and respiratory symptoms in a general population
Source: Annual Congress 2007 - Longitudinal and cross sectional risk factors for COPD
Year: 2007
Determinants of success
Source: Eur Respir J 2011; 38: 1215-1218
Year: 2011
Epidemiological aspects and early detection of chronic obstructive airway diseases in the elderly
Source: Eur Respir J 2003; 21: 3S-9S
Year: 2003
Acute coronary events during acute exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2007 - Clinical aspects in COPD
Year: 2007
Similarities and differences between asthma and chronic obstructive pulmonary disease: treatment and early outcomes
Source: Eur Respir J 2003; 21: 30S-35S
Year: 2003
Chronic bronchitis among French adults: high prevalence and underdiagnosis
Source: Eur Respir J 2002; 20: 806-812
Year: 2002
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept